Metyrapone alleviates ischemic neuronal damage in the gerbil hippocampus.
Transient forebrain ischemia was induced in gerbils, and the effect of a pre-ischemic treatment with metyrapone (100 mg/kg) on delayed neuronal death in hippocampal CA1 neurons was evaluated. The effect of metyrapone on the ischemic release of amino acids in the CA1 region was also examined by microdialysis. Hippocampal slices were used for the evaluation of the hypoxia-induced intracellular Ca2+ increase by microfluorometry. The metyrapone treatment morphologically improved the damage provoked by 3 min of ischemia, although it did not alleviate the damage by 5 min. Ischemia for 3 min produced a 306% increase in the glutamate concentration in perfusates, and metyrapone suppressed the peak value to 42% of that in the control group. The extent of the increase in fluorescence intensity by intracellular Ca2+ was lower by 16% in slices from metyrapone-treated animals than in controls 600 s after induction of hypoxia. The removal of Ca2+ from the perfusion medium suppressed the hypoxic Ca2+ increase, and the increase was further reduced in slices pretreated with metyrapone. The increase in the level of endogenous glucocorticoids, which occurs in cerebral ischemia, may aggravate ischemic neuronal damage.
Department of Anesthesiology and Resuscitology, Ehime University School of Medicine, Onsen-gun, Japan.
N
N
Adachi
J
J
Chen
K
K
Liu
T
T
Nagaro
T
T
Arai
D000596:Amino Acids / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001224:Aspartic Acid / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D003592:Cytophotometry; D005849:Gerbillinae; D005971:Glutamates / Q000187:drug effects / Q000378:metabolism; D005998:Glycine / Q000187:drug effects / Q000378:metabolism; D006624:Hippocampus / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D066298:In Vitro Techniques; D002546:Ischemic Attack, Transient / Q000378:metabolism*; D008297:Male; D008797:Metyrapone / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects* / Q000473:pathology; D016548:Prosencephalon / Q000187:drug effects / Q000378:metabolism / Q000473:pathology
D000596:Amino Acids; D005971:Glutamates; D001224:Aspartic Acid; D002118:Calcium; D005998:Glycine; D008797:Metyrapone